 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval. j2 D! U$ }1 \6 v6 A. ~! T
( D' }+ u" H* y9 Y3 qEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.9 Y# n _% m; o/ w
# b# d$ r a# \ z( X- f9 z/ V' h* f! XBY THE EDMONTON JOURNAL FEBRUARY 16, 20079 F' }% a: b! x6 `$ O b5 X
$ t/ k G& O- d0 P, k
X/ s$ v6 m& C& v6 V. y& F
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.- ~ {3 h, U; }+ [& j/ T
! f- }3 Z+ Q1 J
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."7 W' G5 B# C4 o6 ]& l8 n* o
: }6 f' }% y" F* w5 Y v
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.0 [' P+ k. e- V2 S% s" d& @
% y/ }* ~! i! F) q
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
5 ~/ m+ a; H! g3 e4 d" _$ V, Q( l" c' t" |( ^4 k7 ]8 `! J
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.# U/ m8 z0 G! e9 v* f" \7 ]/ f7 J# ~
8 ?: ~# h' v! T8 Y6 [* P
"As a scientist, it's one of the highlights of my CAREER," Shan said.7 A4 J* r' V7 C- J. } k
; U' S. ~9 @, c y"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."/ H4 m" p& [! x' N* S" j
( K9 ]+ u% i' X# D2 }7 WIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
" ~0 z% o7 k& o/ |9 g
, e0 t6 B8 H1 T. aGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.2 x g" A* {: F4 [8 E+ U
) V4 A; H) Y: B5 W7 eThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
' _( p& P9 y6 K% M: _
# W q1 s4 \1 o& y# o7 K$ A* K
" h k+ E, v: |! q7 q6 }7 _3 Yhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
